Immune markers | Patients, N = 64 | Controls, N = 18 | ||
---|---|---|---|---|
Name | Signalling | Median (Q1, Q3), pg /ml | Median (Q1, Q3), pg /ml | P-valuef |
IL-1β | Pro-infl. | 1.4 (1.1; 2.0)a | 0.5 (0.3; 0.6)e | < 0.001 |
IL-6 | Pro-infl. | 6.0 (4.0; 8.0) | 2.0 (0.9; 2.3)e | 0.001 |
TNF | Pro-infl. | 25 (14; 38) | 10 (3; 13)e | < 0.001 |
IL-12 | Pro-infl. | 9.0 (6.0; 14.8) | 0.2 (0.0; 7.5)e | 0.030 |
IL-17 | Pro-infl. | 13 (4; 27) | 0.0 (0.0; 0.0)e | < 0.001 |
IFN-γ | Pro-infl. | 46 (22; 77) | 25 (6; 39) | 0.067 |
PDGFBB | Pro-infl. | 17 (7; 37) | 2.0 (0.0; 4.8)e | 0.003 |
IL-8 | Pro-infl. | 10 (8; 13) | 5.0 (3.8; 7.0) | < 0.001 |
Eotaxin | Pro-infl. | 60 (47; 84) | 30 (25; 43) | 0.001 |
IP-10 | Pro-infl. | 574 (424; 732) | 725 (577; 1000) | 0.047 |
MCP-1 | Pro-infl. | 20 (17; 26) | 12 (9; 14) | < 0.001 |
MIP-1α | Pro-infl. | 3.0 (2.0; 4.0) | 2.0 (0.9; 3.0)e | 0.052 |
MIP-1β | Pro-infl. | 54 (46; 65) | 42 (35; 52) | 0.022 |
RANTES | Pro-infl. | 1116 (633; 2711) | 571 (347; 850) | 0.016 |
IL-1ra | Anti-infl. | 67 (42; 103) | 18 (0; 29)e | 0.005 |
IL-10 | Anti-infl. | 0.0 (0.0; 1.1)c | 0.0 (0.0; 0.6)e | 0.839 |
IL-2 | Adaptive | 5.0 (2.3; 8.0) | 0.1 (0.0; 2.3)e | 0.001 |
IL-4 | Adaptive | 2.0 (1.0; 2.0) | 1.0 (1.8; 1.0) | 0.208 |
IL-5 | Adaptive | 1.2 (1.0; 1.5)b | 0.9 (0.8; 1.1)e | < 0.005 |
IL-7 | Adaptive | 6.0 (4.3; 7.8) | 1.3 (0.1; 2.3)e | < 0.001 |
IL-9 | Adaptive | 12 (8; 15) | 3.5 (0.4; 8.3)e | 0.003 |
IL-13 | Adaptive | 4.5 (3.0; 8.0) | 2.0 (1.3; 3.0)e | 0.002 |
IL-15 | Adaptive | 2.5 (0.0; 4.8)d | 0.0 (0.0; 0.0)e | < 0.001 |
GMCSF | Trophic | 13 (9; 18) | 6.0 (0.7; 10.0) | < 0.001 |
GCSF | Trophic | 25. (16; 35) | 0.0 (0.0; 12.3)e | < 0.001 |
bFGF | Trophic | 26 (15; 36) | 0.0 (0.0; 15.5)e | 0.001 |
VEGF | Trophic | 15 (9; 23) | 0.0 (0.0; 1.5)e | < 0.001 |